Roivant Total Assets from 2010 to 2024

ROIV Stock

USD 11.81 0.06 0.51%

Roivant Sciences Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

7.2 B

Current Value

7.6 B

Quarterly Volatility

2.1 B

Credit Downgrade

Yuan Drop

Covid

Check Roivant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roivant Sciences' main balance sheet or income statement drivers, such as Discontinued Operations of 97.9 M, Depreciation And Amortization of 20.9 M or Interest Expense of 36.5 M, as well as many indicators such as Price To Sales Ratio of 62.19, Dividend Yield of 6.0E-4 or PTB Ratio of 2.15. Roivant financial statements analysis is a perfect complement when working with Roivant Sciences Valuation or Volatility modules.

Check out the analysis of Roivant Sciences Correlation against competitors.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

Latest Roivant Sciences' Total Assets Growth Pattern

Below is the plot of the Total Assets of Roivant Sciences over the last few years. Total assets refers to the total amount of Roivant Sciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Roivant Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Roivant Sciences' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Roivant Sciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 7.22 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Roivant Total Assets Regression Statistics

	Arithmetic Mean	2,489,192,073
	Geometric Mean	2,031,587,200
	Coefficient Of Variation	82.68
	Mean Deviation	1,336,552,108
	Median	1,387,813,000
	Standard Deviation	2,058,150,694
	Sample Variance	4235984.3T
	Range	6.2B
	R-Value	0.73
	Mean Square Error	2136375.8T
	R-Squared	0.53
	Significance	0
	Slope	335,574,635
	Total Sum of Squares	59303779.9T

Roivant Total Assets History

	2024	7.6 B
	2023	7.2 B
	2022	2.4 B
	2021	2.6 B
	2020	2.6 B
	2019	2.5 B

Other Fundumenentals of Roivant Sciences

Intangibles To Total Assets

Roivant Sciences Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment	Long Term Debt	Deferred Long Term Liab	Net Invested Capital	Long Term Investments	Net Working Capital	Short Term Investments	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Intangible Assets
Total Assets		1.0	0.49	0.01	-0.99	0.86	0.78	0.97	0.69	1.0	0.03	0.53	0.8	0.66	0.81	-0.79	0.81	0.89	0.77	0.89	-0.94	-0.82
Total Stockholder Equity	1.0		0.52	0.0	-1.0	0.86	0.78	0.96	0.67	1.0	0.0	0.55	0.79	0.67	0.8	-0.77	0.8	0.88	0.76	0.88	-0.93	-0.81
Net Tangible Assets	0.49	0.52		0.02	-0.51	0.41	0.48	0.3	0.2	0.47	-0.39	0.9	0.23	0.35	0.15	-0.09	0.15	0.21	0.17	0.21	-0.24	-0.33
Current Deferred Revenue	0.01	0.0	0.02		0.05	-0.43	0.43	0.12	0.63	-0.03	0.86	0.17	0.52	0.5	-0.16	0.25	-0.17	0.28	0.52	0.27	0.09	0.08
Net Debt	-0.99	-1.0	-0.51	0.05		-0.89	-0.77	-0.95	-0.65	-1.0	0.04	-0.55	-0.77	-0.64	-0.84	0.78	-0.84	-0.88	-0.75	-0.88	0.95	0.78
Retained Earnings	0.86	0.86	0.41	-0.43	-0.89		0.41	0.81	0.26	0.88	-0.34	0.45	0.46	0.25	0.79	-0.89	0.8	0.67	0.46	0.67	-0.87	-0.74
Accounts Payable	0.78	0.78	0.48	0.43	-0.77	0.41		0.73	0.91	0.75	0.28	0.5	0.9	0.96	0.67	-0.29	0.68	0.84	0.86	0.84	-0.71	-0.39
Net Receivables	0.97	0.96	0.3	0.12	-0.95	0.81	0.73		0.74	0.97	0.23	0.41	0.86	0.63	0.81	-0.85	0.8	0.94	0.85	0.94	-0.95	-0.82
Total Liab	0.69	0.67	0.2	0.63	-0.65	0.26	0.91	0.74		0.66	0.61	0.33	0.95	0.89	0.59	-0.34	0.59	0.87	0.94	0.86	-0.66	-0.4
Total Current Assets	1.0	1.0	0.47	-0.03	-1.0	0.88	0.75	0.97	0.66		0.01	0.51	0.78	0.63	0.82	-0.81	0.82	0.88	0.76	0.88	-0.95	-0.82
Short Term Debt	0.03	0.0	-0.39	0.86	0.04	-0.34	0.28	0.23	0.61	0.01		-0.19	0.54	0.38	-0.04	-0.01	-0.05	0.36	0.56	0.36	-0.05	-0.06
Property Plant Equipment	0.53	0.55	0.9	0.17	-0.55	0.45	0.5	0.41	0.33	0.51	-0.19		0.36	0.29	0.26	-0.27	0.26	0.36	0.35	0.36	-0.33	-0.3
Long Term Debt	0.8	0.79	0.23	0.52	-0.77	0.46	0.9	0.86	0.95	0.78	0.54	0.36		0.87	0.72	-0.51	0.71	0.96	0.99	0.95	-0.79	-0.5
Deferred Long Term Liab	0.66	0.67	0.35	0.5	-0.64	0.25	0.96	0.63	0.89	0.63	0.38	0.29	0.87		0.56	-0.14	0.57	0.77	0.82	0.77	-0.61	-0.32
Net Invested Capital	0.81	0.8	0.15	-0.16	-0.84	0.79	0.67	0.81	0.59	0.82	-0.04	0.26	0.72	0.56		-0.71	1.0	0.87	0.74	0.88	-0.94	-0.43
Long Term Investments	-0.79	-0.77	-0.09	0.25	0.78	-0.89	-0.29	-0.85	-0.34	-0.81	-0.01	-0.27	-0.51	-0.14	-0.71		-0.71	-0.7	-0.54	-0.7	0.84	0.8
Net Working Capital	0.81	0.8	0.15	-0.17	-0.84	0.8	0.68	0.8	0.59	0.82	-0.05	0.26	0.71	0.57	1.0	-0.71		0.87	0.74	0.87	-0.94	-0.43
Short Term Investments	0.89	0.88	0.21	0.28	-0.88	0.67	0.84	0.94	0.87	0.88	0.36	0.36	0.96	0.77	0.87	-0.7	0.87		0.96	1.0	-0.93	-0.58
Long Term Debt Total	0.77	0.76	0.17	0.52	-0.75	0.46	0.86	0.85	0.94	0.76	0.56	0.35	0.99	0.82	0.74	-0.54	0.74	0.96		0.96	-0.8	-0.46
Capital Surpluse	0.89	0.88	0.21	0.27	-0.88	0.67	0.84	0.94	0.86	0.88	0.36	0.36	0.95	0.77	0.88	-0.7	0.87	1.0	0.96		-0.93	-0.59
Short Long Term Debt	-0.94	-0.93	-0.24	0.09	0.95	-0.87	-0.71	-0.95	-0.66	-0.95	-0.05	-0.33	-0.79	-0.61	-0.94	0.84	-0.94	-0.93	-0.8	-0.93		0.7
Intangible Assets	-0.82	-0.81	-0.33	0.08	0.78	-0.74	-0.39	-0.82	-0.4	-0.82	-0.06	-0.3	-0.5	-0.32	-0.43	0.8	-0.43	-0.58	-0.46	-0.59	0.7

Click cells to compare fundamentals

About Roivant Sciences Financial Statements

Roivant Sciences investors use historical fundamental indicators, such as Roivant Sciences' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Roivant Sciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	7.2 B	7.6 B
Intangibles To Total Assets	0.02	0.02

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC